title: Effects of nonylphenol and triclosan on production of plasma vitellogenin and testosterone in male South African clawed frogs (Xenopus laevis).
abstract: We investigated the effects of nonylphenol (NP) and triclosan (TCS) on production of vitellogenin (Vg), testosterone (T), and hepatic cytochrome P450 1A and 2B activities in male South African clawed frogs (Xenopus laevis). In a 14-d waterborne exposure test, no significant differences in the level of plasma Vg synthesis in male frogs were observed among the control, 10, 50, and 100 microg/l NP and 20, 100, and 200 microg/l TCS treatment groups. Intraperitoneal injection of male frogs with 2, 20, and 200 microg/g body weight NP resulted in no significant differences in plasma Vg levels among the control and all treatment groups. However, the levels of plasma Vg in all TCS treatment groups (intraperitoneal injection of 4, 40, and 400 microg/g body weight) were lower than that in the solvent control group, and male frogs injected with high doses of NP or TCS had lower T levels than the control group. No significant differences in hepatic cytochrome P450 1A and 2B activities were observed among the all treatment groups. Male frogs injected with 20 microg/g body weight of estradiol-17beta had significantly higher plasma Vg levels than the control group. These results suggest that profiles of plasma Vg and T production in male Xenopus laevis could be useful biomarkers for detecting hormonally active agents.
authors.affiliation: Faculty of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto, Japan.
authors.forename: Naomi
authors.initials: N
authors.lastname: Matsumura
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Ishibashi
authors.forename: Masashi
authors.initials: M
authors.lastname: Hirano
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Nagao
authors.forename: Naoko
authors.initials: N
authors.lastname: Watanabe
authors.forename: Hideki
authors.initials: H
authors.lastname: Shiratsuchi
authors.forename: Toshinori
authors.initials: T
authors.lastname: Kai
authors.forename: Tetsuji
authors.initials: T
authors.lastname: Nishimura
authors.forename: Akihiko
authors.initials: A
authors.lastname: Kashiwagi
authors.forename: Koji
authors.initials: K
authors.lastname: Arizono
mesh_terms: D000818:Animals; D019363:Cytochrome P-450 CYP1A1 / Q000378:metabolism; D019362:Cytochrome P-450 CYP2B1 / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D007274:Injections, Intraperitoneal; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D010636:Phenols / Q000494:pharmacology*; D013739:Testosterone / Q000097:blood*; D014260:Triclosan / Q000494:pharmacology*; D014819:Vitellogenins / Q000097:blood*; D014982:Xenopus laevis
chemical_list: D010636:Phenols; D014819:Vitellogenins; D013739:Testosterone; D014260:Triclosan; C025256:nonylphenol; D019363:Cytochrome P-450 CYP1A1; D019362:Cytochrome P-450 CYP2B1